Connect
MJA
MJA

Cardiovascular diseases

Research

Evaluating recruitment strategies for AUSPICE, a large Australian community‐based randomised controlled trial

Roseanne Peel, Shu Ren, Alexis Hure, Tiffany‐Jane Evans, Catherine A D'Este, Walter P Abhayaratna, Andrew M Tonkin, Ingrid Hopper, Amanda G Thrift, Christopher R Levi, Jonathan Sturm, David Durrheim, Joseph Hung, Tom G Briffa, Derek P Chew, Phil Anderson, Lynelle Moon, Mark McEvoy, Philip M Hansbro, David A Newby and John R Attia

Med J Aust 2019; 210 (9): 409-415 Free

Narrative reviews

An updated review of lipid‐modifying therapy

Leon A Simons

Med J Aust 2019; 211 (2): 87-92

Editorials

Rapid access clinics for patients with chest pain: will they work in Australia?

Clara K Chow and Adam Timmis

Med J Aust 2019; 210 (7): 307-308

Narrative reviews

Coexisting chronic obstructive pulmonary disease and cardiovascular disease in clinical practice: a diagnostic and therapeutic challenge

Paul Leong, Martin I Macdonald, Brian S Ko and Phil G Bardin

Med J Aust 2019; 210 (9): 417-423

Medical education / Snapshot

Carotid sinus hypersensitivity

Vahid Moosavi and Mohammad Paymard

Med J Aust 2019; 210 (6): 257

Research

Evaluating the benefits of a rapid access chest pain clinic in Australia

James Andrew Black, Kevin Cheng, Jo‐Anne Flood, Garry Hamilton, Serena Parker, Anees Enayati, Faisal S Khan and Tom Marwick

Med J Aust 2019; 210 (7): 321-325 Free

Editorials

Developing cardiovascular risk prediction models for Australia

Mark R Nelson and Mark Woodward

Med J Aust 2019; 210 (4): 158-159

Editorials

Engaging GPs and primary care patients in research: implications of the ASPREE trial for future studies

James P Sheppard and Chris Butler

Med J Aust 2019; 210 (4): 159-160

Research

External validation and comparison of four cardiovascular risk prediction models with data from the Australian Diabetes, Obesity and Lifestyle study

Loai Albarqouni, Jennifer A Doust, Dianna Magliano, Elizabeth LM Barr, Jonathan E Shaw and Paul P Glasziou

Med J Aust 2019; 210 (4): 161-167 Free

Research

Intensive lipid‐lowering therapy in the 12 months after an acute coronary syndrome in Australia: an observational analysis

David Brieger, Mario D'Souza, Karice Hyun, James C Weaver and Leonard Kritharides

Med J Aust 2019; 210 (2): 80-85 Free

Editorials

Reducing cardiovascular risk in people with diabetes and kidney disease

Brendon L Neuen and Vlado Perkovic

Med J Aust 2018; 209 (10): 438-439

Research

Type 2 diabetes in patients with end-stage kidney disease: influence on cardiovascular disease-related mortality risk

Wai H Lim, David W Johnson, Carmel Hawley, Charmaine Lok, Kevan R Polkinghorne, Matthew A Roberts, Neil Boudville and Germaine Wong

Med J Aust 2018; 209 (10): 440-446 Free

Letters

Absolute cardiovascular disease risk and lipid-lowering therapy among Aboriginal and Torres Strait Islander Australians

Rosalie Schultz

Med J Aust 2018; 209 (8): 369

Letters

Absolute cardiovascular disease risk and lipid-lowering therapy among Aboriginal and Torres Strait Islander Australians

Raymond W Lovett

Med J Aust 2018; 209 (8): 368-370

Perspectives

The rising health, social and economic costs of Australia’s ageing prisoner population

Natasha A Ginnivan, Tony G Butler and Adrienne N Withall

Med J Aust 2018; 209 (10): 422-424

Medical education / Lessons from practice

Brugada syndrome and undifferentiated syncope: use of an implantable loop recorder to document causation

Garry Hamilton, David O'Donnell and Hui-Chen Han

Med J Aust 2018; 209 (3): 113-114

Editorials

Why are women with ST-elevation myocardial infarction treated differently to men?

Andrew I MacIsaac and Gemma Figtree

Med J Aust 2018; 209 (3): 115-116

Editorials

The epidemiology and costs of implantable cardioverter–defibrillator therapy in Australia

Jitendra Vohra and Haris M Haqqani

Med J Aust 2018; 209 (3): 116-117

Narrative review

Transcatheter aortic valve implantation: a new standard of care

Adam J Nelson, Nicholas J Montarello, Claudia S Cosgrove, Ross L Roberts-Thomson, Sinny Delacroix, Ramesh G Chokka, Joseph K Montarello and Stephen G Worthley

Med J Aust 2018; 209 (3): 136-141

Perspectives

Public reporting of percutaneous coronary interventions

David Enze Wang, Rishi K Wadhera and Deepak L Bhatt

Med J Aust 2018; 209 (3): 104-105

Perspectives

Potential implications of the new American hypertension guidelines in Australia

Garry LR Jennings, Bronwyn A Kingwell and Erin Hoare

Med J Aust 2018; 209 (3): 108-109

Guideline summary

National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018

David Brieger, John Amerena, John R Attia, Beata Bajorek, Kim H Chan, Cia Connell, Ben Freedman, Caleb Ferguson, Tanya Hall, Haris M Haqqani, Jeroen Hendriks, Charlotte M Hespe, Joseph Hung, Jonathan M Kalman, Prashanthan Sanders, John Worthington, Tristan Yan and Nicholas A Zwar

Med J Aust 2018; 209 (8): 356-362 Free

Guideline summary

National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of heart failure 2018

John J Atherton, Andrew Sindone, Carmine G De Pasquale, Andrea Driscoll, Peter S MacDonald, Ingrid Hopper, Peter Kistler, Tom G Briffa, James Wong, Walter P Abhayaratna, Liza Thomas, Ralph Audehm, Phillip J Newton, Joan O'Loughlin, Cia Connell and Maree Branagan

Med J Aust 2018; 209 (8): 363-369 Free

Research

Implantable cardioverter–defibrillator therapy in Australia, 2002–2015

Bianca Blanch, Luise P Lago, Raymond Sy, Phillip J Harris, Christopher Semsarian and Jodie Ingles

Med J Aust 2018; 209 (3): 123-129 Free

Research letter

Delays in primary percutaneous coronary treatment for patients with ST-elevation myocardial infarction

Diem T Dinh, Yishen Wang, Angela L Brennan, Stephen J Duffy, Dion Stub, Christopher M Reid and Jeffrey Lefkovits

Med J Aust 2018; 209 (3): 130-131 Free